论文部分内容阅读
目的观察奥扎格雷钠治疗急性脑梗死的临床效果。方法选取急性脑梗死患者200例,随机分为观察组和对照组各100例。2组均予对症支持治疗,在此基础上,对照组予丹参注射液治疗,观察组予奥扎格雷钠治疗。比较2组临床效果及不良反应发生情况。结果观察组总有效率为98.0%,高于对照组的64.0%(P<0.05)。2组治疗过程中均未出现不良反应。结论奥扎格雷钠治疗急性脑梗死效果显著,可明显改善急性脑梗死患者脑细胞及神经功能,且不良反应少,值得临床推广应用。
Objective To observe the clinical effect of ozagrel sodium on acute cerebral infarction. Methods 200 patients with acute cerebral infarction were randomly divided into observation group and control group of 100 cases. Two groups were symptomatic supportive treatment, on this basis, the control group to Salvia injection, the observation group was given ozagrel sodium treatment. The clinical effects and adverse reactions in two groups were compared. Results The total effective rate in observation group was 98.0%, which was higher than that in control group (64.0%, P <0.05). No adverse reactions occurred in the two groups during the treatment. Conclusion Ozagrel sodium treatment of acute cerebral infarction significant effect, can significantly improve patients with acute cerebral infarction brain cells and neurological function, and less adverse reactions, it is worth promoting the clinical application.